As the market struggled with Congress’ indecision regarding a new Covid relief package, tech, biotech, and IPOs offered support.
If you are already a subscriber, click the login button below to get access. Not yet a subscriber? Checkout our publication below and get access today!
Despite all of the drama, it seems investors just don’t care about who occupies the White House — shrugging off all the talk of fraud, recounts and peaceful transitions of power.
As the market digests the news of Trump’s coronavirus diagnosis, let’s look at what our editors are expecting from Wall Street…
There’s a nationwide coin shortage. And while it’s become an inconvenience to one of our analysts, it could lead to some unique opportunities for you...
Gold finally topped $2,000 an ounce last week — but most analysts have overlooked the biggest reason behind the surge. Here’s what it means for your money…
We’re bringing together some of the top talent in the financial publishing business so that we can bring the best ideas and strategies to you! Here's what to look out for...
